secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2023-07-14T23:59:59+00:00
Accession:  0001437749-23-019971
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key receives additional 180-day Nasdaq compliance period until Jan 8, 2024 for bid price rule
--------------------------------------------------------------------------------

- Received deficiency letter on Jan 12, 2023 for bid price below $1.00 for 30 consecutive days.
- On July 12, 2023, Nasdaq granted additional 180-day period until Jan 8, 2024 to regain compliance.
- To regain compliance, closing bid price must be at least $1.00 for 10 consecutive business days.
- Company may effect reverse stock split to cure deficiency if needed.
- If not compliant by Jan 8, 2024, Nasdaq will delist and company can appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774923019971/0001437749-23-019971-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774923019971/bkyi20230714_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-019971

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer